CMS Ready to Impose Plan Reform

December 1, 2003

Dermatologists who administer chemotherapy and other drugs in their offices could see significant reductions in reimbursement levels as a result of an effort by the federal government to curtail Medicare's costs for drugs used to treat cancer.

Related Content:

Practice Management